Galvin Gaustad & Stein’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Galvin Gaustad & Stein's LLY Position: Q1 2026 in Review
Galvin Gaustad & Stein reduced its Eli Lilly (LLY) stake by 1.7% in Q1 2026, selling an estimated $23.3K and leaving 1,324 shares worth $1.22M. The position accounts for 0.1% of the portfolio, ranked #116.
Galvin Gaustad & Stein first reported a position in LLY in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.77M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Galvin Gaustad & Stein held 1,324 shares of Eli Lilly worth $1.22M as of Q1 2026.
- Galvin Gaustad & Stein sold 23 Eli Lilly shares in Q1 2026, an estimated $23.3K.
- Eli Lilly made up 0.1% of Galvin Gaustad & Stein's portfolio in Q1 2026, its #116 holding.
- Galvin Gaustad & Stein first reported a position in Eli Lilly in Q4 2020 and has held it in 22 quarters since.
- Galvin Gaustad & Stein's Eli Lilly position peaked at $1.77M in Q2 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Galvin Gaustad & Stein's 13F filing for Q1 2026, filed 14 May 2026.